Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: Reuters Investment Profile
Provider: Thomson Reuters Stock Report
Provider: Ford Investor Services, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Aratana Therapeutics Inc Announces Full Exercise Of Over Allotment Option

Thursday, 11 Jul 2013 07:00pm EDT 

Aratana Therapeutics Inc announced the full exercise of the over-allotment option granted to the underwriters to purchase 862,500 additional shares of common stock, at a public offering price of $6.00 per share, in connection with its previously announced initial public offering of 5,750,000 shares of common stock that closed on July 2, 2013, bringing the total gross proceeds from the offering to $39,675,000, before deducting the underwriting discounts and commissions and other offering expenses payable by Aratana Therapeutics. The company's common stock is listed on The NASDAQ Global Market under the trading symbol "PETX." Stifel and Lazard Capital Markets acted as lead book-running managers for the offering. William Blair, JMP Securities and Craig-Hallum Capital Group acted as co-managers. 

Company Quote

-0.22 -1.34%
27 Mar 2015